GTX Inc (NASDAQ:GTXI)

15.46
Delayed Data
As of Feb 21
 -1.25 / -7.48%
Today’s Change
2.73
Today|||52-Week Range
17.00
+21.64%
Year-to-Date
No recent news for GTX Inc.

Today’s Trading

Previous close16.71
Today’s open16.71
Day’s range15.22 - 16.71
Volume103,306
Average volume (3 months)56,905
Market cap$333.0M
Data as of 4:00pm ET, 02/21/2018

Growth & Valuation

Earnings growth (last year)+18.67%
Earnings growth (this year)-31.56%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book12.37

Competitors

 Today’s
change
Today’s
% change
RGLSRegulus Therapeutics...-0.02-1.63%
GLMDGalmed Pharmaceutica...+0.29+5.44%
ZFGNZafgen Inc+0.05+0.64%
MEIPMEI Pharma Inc-0.09-4.11%
Data as of 4:00pm ET, 02/21/2018

Financials

Next reporting dateMarch 14, 2018
EPS forecast (this quarter)-$0.39
Annual revenue (last year)$0.00
Annual profit (last year)-$17.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Marc Steven Hanover
Principal Financial &
Accounting Officer
Jason T. Shackelford
Corporate headquarters
Memphis, Tennessee

Forecasts